Quest Diagnostics (DGX) said Wednesday that it now expects that worse-than-expected weather to trim Q1 revenue by $25 million and EPS by $0.10.
The medical testing services company also said it continues to expect 2025 adjusted diluted earnings of $9.55 to $9.80 per share on net revenue of $10.70 billion to $10.85 billion.
Analysts polled by FactSet expect non-GAAP EPS of $9.71 on sales of $10.79 billion.
Shares of the company were down more than 1% in recent premarket activity on Wednesday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。